Peterson Cora, Dawson April, Grosse Scott D, Riehle-Colarusso Tiffany, Olney Richard S, Tanner Jean Paul, Kirby Russell S, Correia Jane A, Watkins Sharon M, Cassell Cynthia H
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Birth Defects Res A Clin Mol Teratol. 2013 Oct;97(10):664-72. doi: 10.1002/bdra.23165. Epub 2013 Sep 2.
Critical congenital heart disease (CCHD) was recently added to the U.S. Recommended Uniform Screening Panel for newborns. States considering screening requirements may want more information about the potential impact of screening. This study examined potentially avoidable mortality among infants with late detected CCHD and assessed whether late detection was associated with increased hospital resource use during infancy.
This was a state-wide, population-based, observational study of infants with CCHD (n = 3603) born 1998 to 2007 identified by the Florida Birth Defects Registry. We examined 12 CCHD conditions that are targets of newborn screening. Late detection was defined as CCHD diagnosis after the birth hospitalization. Deaths potentially avoidable through screening were defined as those that occurred outside a hospital following birth hospitalization discharge and those that occurred within 3 days of an emergency readmission.
For 23% (n = 825) of infants, CCHD was not detected during the birth hospitalization. Death occurred among 20% (n = 568/2,778) of infants with timely detected CCHD and 8% (n = 66/825) of infants with late detected CCHD, unadjusted for clinical characteristics. Potentially preventable deaths occurred in 1.8% (n = 15/825) of infants with late detected CCHD (0.4% of all infants with CCHD). In multivariable models adjusted for selected characteristics, late CCHD detection was significantly associated with 52% more admissions, 18% more hospitalized days, and 35% higher inpatient costs during infancy.
Increased CCHD detection at birth hospitals through screening may lead to decreased hospital costs and avoid some deaths during infancy. Additional studies conducted after screening implementation are needed to confirm these findings.
严重先天性心脏病(CCHD)最近被纳入美国新生儿推荐统一筛查项目。考虑制定筛查要求的各州可能希望获取更多有关筛查潜在影响的信息。本研究调查了CCHD诊断延迟的婴儿中潜在可避免的死亡率,并评估了诊断延迟是否与婴儿期医院资源使用增加相关。
这是一项基于佛罗里达州出生缺陷登记处识别出的1998年至2007年出生的患有CCHD的婴儿(n = 3603)的全州性、基于人群的观察性研究。我们研究了12种作为新生儿筛查目标的CCHD病症。诊断延迟定义为出生住院后诊断出CCHD。通过筛查可能避免的死亡定义为出生住院出院后在院外发生的死亡以及紧急再次入院后3天内发生的死亡。
23%(n = 825)的婴儿在出生住院期间未检测出CCHD。在未根据临床特征进行调整的情况下,及时诊断出CCHD的婴儿中有20%(n = 568/2778)死亡,诊断延迟的婴儿中有8%(n = 66/825)死亡。诊断延迟的CCHD婴儿中有1.8%(n = 15/825)发生了潜在可预防的死亡(占所有CCHD婴儿的0.4%)。在针对选定特征进行调整的多变量模型中,CCHD诊断延迟与婴儿期入院次数增加52%、住院天数增加18%以及住院费用增加35%显著相关。
通过筛查增加出生医院对CCHD的检测可能会降低医院成本,并避免婴儿期的一些死亡情况。在筛查实施后还需要进行更多研究以证实这些发现。